Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.

Doll, Sophia; Urisman, Anatoly; Oses-Prieto, Juan A; Arnott, David; Burlingame, Alma L

Doll, Sophia; Urisman, Anatoly; Oses-Prieto, Juan A; Arnott, David; Burlingame, Alma L.

Affiliation

Doll S; From the Department of Pharmaceutical Chemistry, University of California, San Francisco, 94158-2517 California.
Urisman A; From the Department of Pharmaceutical Chemistry, University of California, San Francisco, 94158-2517 California.
Oses-Prieto JA; From the Department of Pharmaceutical Chemistry, University of California, San Francisco, 94158-2517 California.
Arnott D; §Department of Protein Chemistry, Genentech Inc, South San Francisco, 94158-2517 California.
Burlingame AL; From the Department of Pharmaceutical Chemistry, University of California, San Francisco, 94158-2517 California; alb@cgl.ucsf.edu.

Mol Cell Proteomics ; 16(1): 39-56, 2017 01.

Article in En | MEDLINE | ID: mdl-27834733

Subject(s)

Brain Neoplasms/pathology; Glioblastoma/pathology; Isocitrate Dehydrogenase/genetics; Phosphoproteins/analysis; Proteomics/methods; Proto-Oncogene Proteins p21(ras)/genetics; Brain Neoplasms/genetics; Brain Neoplasms/metabolism; Cell Line, Tumor; Glioblastoma/genetics; Glioblastoma/metabolism; Histone Code; Histones/metabolism; Humans; Mitogen-Activated Protein Kinases/metabolism; Mutation; Phosphatidylinositol 3-Kinases/metabolism; Protein Interaction Maps; Signal Transduction; TOR Serine-Threonine Kinases/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphoproteins / Brain Neoplasms / Proto-Oncogene Proteins p21(ras) / Glioblastoma / Proteomics / Isocitrate Dehydrogenase Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cell Proteomics Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2017 Type: Article

Fulltext

XML

PubMed Links

Search on Google